The “Wolverine Stack” combines BPC-157 and TB-500 to create the most popular recovery & localised injury healing peptide blend on the market. SEQUORA’s BPC-157 & TB-500 20mg blend can be used daily to either aid with localised injury recovery, increased dosing to aggresively heal injuries or once every two days for maintenance and general aches & pains.
Already have an account? Log in
SEQUORA Wolverine Stack (BPC-157 & TB-500) is a two-compound research blend containing 10mg each of BPC-157 & TB-500. Available in vial and prefilled pen formats. These individual compounds have been researched to support fast recovery, tissue repair and reduced inflammation in the body helping recover from exercise fatigue and even injury.
The 20mg figure indicates the total stated content across both compounds, not the concentration or amount delivered per withdrawal. Review the specifications for your selected format.
All of our products are third party laboratory tested to ensure both purity and verification of the peptide itself.
The Wolverine Stack is the coined name for combining BPC-157 and TB-500. It is commonly used in relation to injury recovery and tissue repair, SEQUORA’s Wolverine Stack combines 10mg of BPC-157 with 10mg of TB-500.
Research & Clinical Trials show that BPC-157 (Body Protection Compound) excels at localised tissue repair while TB-500 (Thymosin Beta-4 Fragment) provides systemic anti-inflammatory effects and promotes cellular migration towards injuries. They work together to heal both tissue damage and aid with overall systemic recovery.
The convenience of taking both blends is better suited to injury recovery and general localised injury healing. However if you primarily want the TB-500 benefits (anti-inflammatory and fibrosis reductions) then it may be beneficial to split dose each individual compound as you will want more TB-500 than BPC-157.
Your goal with using the Wolverine Stack is what will alter cycle length, please refer to our dosing guidance for more information on general maintenance dosage, aggressive injury healing or recovery. However you should notice the effects of BPC-157 & TB-500 within 1-2 weeks, and the full effects and tissue remodelling by Weeks 5-8.
Product information, handling and safety
What Temperature should I store my Wolverine Stack at?
What are the best practices for using Wolverine Stack safely?
The documentation behind Wolverine Stack and it's uses
The “Wolverine Stack” combines BPC-157 and TB-500 to create the most popular recovery & localised injury healing peptide blend on the market. SEQUORA’s BPC-157 & TB-500 20mg blend can be used daily to either aid with localised injury recovery, increased dosing to aggresively heal injuries or once every two days for maintenance and general aches & pains.
Upon delivery store in a refridgerator between 2-8°C.
Avoid dropping or heavy-handling of your BPC-157 & TB-500 Blend.
Please do not freeze your SEQUORA Wolverine Stack Pen as this can compromise the individual peptides.
Your product has been shipped in secure packaging to prevent any potential issues however if you believe your peptides have been compromised contact us directly.
Your SEQUORA Wolverine Stack Pen will last 12 months from the date of manufacture providing you follow the storage instructions provided.
SEQUORA BPC-157 & TB-500 Blend Vials before reconstitution can last up to 4 years at -5°C
The SEQUORA Wolverine Stack Pen can be kept at room temperature however it’s shelf life when held at this temperature reduces to 1-2 months.
Before handling any peptides, needles or injection material ensure your research area is clean and clear.
Wash your hands with warm water and soap and allow to dry fully before handling the BPC-157 & TB-500 Blend to prevent cross contamination or infection risks.
If at any point the cleanliness of your injection or environment is compromised, restart this step.
Never re-use or share needles/syringes. Ensure your needle tips or syringe is sealed and new before injection.
Before using your SEQUORA Wolverine Stack Pen, using an alcohol swab, wipe the tip of the cartridge after removing the lid to the pen.
If at any point you touch something unhygienic or potentially dirty, re-wash your hands and use new equipment.
Ensure that your needle tips, syringes and vials are safely disposed of post-use.
This could mean a sharps bin or safe container. Most needle tips and syringes have removable tops that can be replaced onto the used needle.
Try to keep your injection site clean for atleast 30 minutes post-injection to prevent infection risks.
Human safety information for the BPC-157/TB-500 blend is limited. The following symptoms have been described in personal reports, but their frequency, cause and typical duration have not been established.
Reported symptoms
These symptoms should not automatically be considered harmless or expected to disappear within a few days. Reports cannot reliably distinguish effects of the peptides from the diluent, administration technique or product quality.
Cancer-related precautions
Effects on blood-vessel formation, known as angiogenesis, have been investigated in laboratory and animal research involving these biological pathways. This raises theoretical concerns in the presence of an existing tumour, but does not establish that this blend causes cancer or accelerates cancer in humans.
People with active cancer or a history of cancer should avoid self-experimentation and discuss any proposed exposure with their oncology team.
Pregnancy and breastfeeding
Avoid use during pregnancy or breastfeeding because adequate safety data are unavailable.
About this information
Limited human evidence means that an excellent safety profile, absence of significant adverse effects or a safe standard dose cannot be established for this blend. This information does not replace individual medical advice.
No clinically validated mitigation protocol has been established for the BPC-157/TB-500 blend. The following precautions address the reported symptoms and uncertainties listed below.
Injection-site redness, irritation or warmth
Dizziness or lightheadedness
Tiredness or lethargy
Cancer-related precautions
Do not self-experiment with this blend if you have active cancer or a history of cancer. Discuss the theoretical angiogenesis concern with your oncology team. Lower doses, shorter cycles or breaks have not been shown to remove this uncertainty.
Pregnancy and breastfeeding
Avoid use during pregnancy or breastfeeding. If exposure has occurred, contact your healthcare professional for individual advice rather than assuming that harm has occurred.
About this information
These precautions do not establish the blend’s safety or suitability for injection. Human clinical data remain limited and personal reports cannot establish a safe dose, duration or effective mitigation strategy.
The Wolverine Stack (TB-500 & BPC-157) should be injected daily when targeting a specific injury or recovery period, if being used as a general maintenance dose for aches and pains we advise an injection every two days.
Calculation basis: 20 mg total compound in a final volume of 2.4 ml, with 0.01 ml delivered per pen dial unit.
| Protocol | Amount | Pen dial setting | Frequency | Injection Area | Duration |
|---|---|---|---|---|---|
| Recovery | 250 mcg | 3 | 1x daily | Close to Injury Site | 4-6 weeks |
| Aggressive Healing | 500 mcg | 6 | 1x daily | Close to Injury Site | 4-8 weeks |
| Maintenance/General Use | 250 mcg | 3 | Every other day | Stomach/Abdomen | 2-4 weeks |
Understanding the figures
Doses are expressed in milligrams per daily administration. Each numbered dial of the pen delivers 0.01ml of liquid or 1 Unit. The SEQUORA 20mg “Wolverine Stack” Pen contains 2.4ml of reconstituted TB-500 & BPC-157 meaning every 1 dial = Approximately 83.3 mcg of Total Blend (41.515 mcg of TB-500 / 41.515 mcg of BPC-157).